Similar articles

• [Prevention of hepatocellular carcinogenesis by interferon].

  Ikeda K. Ikeda K. Nihon Rinsho. 2001 Oct;59 Suppl 6:755-63. Nihon Rinsho. 2001. PMID: 11762051 Review. Japanese. No abstract available.
• [High risk group for development of hepatocellular carcinoma].

  Koike Y, Shiratori Y. Koike Y, et al. Nihon Rinsho. 2001 Oct;59 Suppl 6:362-6. Nihon Rinsho. 2001. PMID: 11761973 Review. Japanese. No abstract available.
• Hepatocellular carcinoma.

  Desjardins LA. Desjardins LA. Clin J Oncol Nurs. 2002 Mar-Apr;6(2):107-8. doi: 10.1188/02.CJON.107-108. Clin J Oncol Nurs. 2002. PMID: 11889672 Review.
• Hepatocellular carcinoma and viral cirrhosis.

  Gentilini P, Melani L, Riccardi D, Casini Raggi V, Romanelli RG. Gentilini P, et al. Hepatology. 1994 Sep;20(3):764-5. Hepatology. 1994. PMID: 8076933 No abstract available.
• [Recurrence and prognosis of hepatitis C virus-related hepatocellular carcinoma--as compared with hepatitis B virus-related cases].

  Kobayashi S, Asano T, Saigoh K, Urashima T, Okazumi S, Abe Y, Takayama W, Isono K. Kobayashi S, et al. Nihon Rinsho. 1995 Sep;53 Suppl(Pt 1):810-4. Nihon Rinsho. 1995. PMID: 7563881 Japanese. No abstract available.